An old friend returned to the big leagues yesterday in a relatively unexpected place. After 11 seasons in the majors, all with the Cardinals, Matt Carpenter found himself searching for a new team this winter; in the end, he only managed to snag a minor league deal with the Rangers. Now, though, he’s found himself in New York with the Yankees, signing a major league deal with them that was announced on Thursday and hitting eighth in the starting lineup for their game against the Rays that same day. Does Carpenter have a second wind, or has too much time passed since he was an effective contributor?
That Carpenter found little interest in his services this winter was hardly surprising. Some players age gracefully, but he fell off a cliff after the 2018 season, dropping from a wRC+ of 140 to 96. If that had been the extent of his collapse, he’d still have a role in the majors; he still managed to collect 1.7 WAR in 492 plate appearances in 2019, thanks to not being awful at second or third base. But after hitting .176/.313/.291 combined over 2020 and ’21, even that saving grace didn’t provide quite enough grace. What rope remained after the COVID-shortened 2020 rapidly ran out of slack the following year, and his role was reduced to the extent that only 11 of his 53 games after the All-Star break were as a starter.
It strikes me as likely that Carpenter only survived on the roster because of his long history with the franchise; infielders who can’t hit are a dime a dozen, and he didn’t have an exploitable platoon split advantage the way a steeply declining Albert Pujols did. And while much has been made of Carpenter’s struggles against the shift, and while he’s been worse throughout his career relative to a traditional infield configuration, it’s not sufficient to explain the collapse. He hit just fine overall as the approach against him shifted (no pun intended) yearly toward all-shift after 2015; by the time 2018 rolled around, when he was still a dangerous offensive player, he was almost exclusively hitting against a stacked right side of the infield. Read the rest of this entry »
Dan Szymborski: OK, just regular chat, but adding Thunder to things always makes them more exciting
12:04
Old Hoss Radbourn: I know xStats are flawed (even more so this year because of the change in offensive environment), but they’re showing Abraham Toro getting insanely unlucky. Is there some bad luck masking a real breakout here?
12:04
Dan Szymborski: I think ther’es some bad luck
12:04
Dan Szymborski: xStat stuff is having *calibration* problems, but it should be an issue of *bias* more than accuracy really
12:05
Dan Szymborski: ZiPS stats are more predictive (with slightly differing methodology) and is similarly overexpecting results
Last week, I discussed some of the young, pre-free agency players who teams should be trying to sign to long-term contract extensions. I hadn’t been planning for there to be a part two, but you guys had so many additional players you wanted to talk about, and I can’t remember the last time I got more DMs about a piece than that one — well, about a piece for which everyone isn’t mad at me, at least!
So, let’s oil up and turn the crank on the ol’ ZiPS-o-Matic and get this projection mill hopping for seven more players.
Walker Buehler, Los Angeles Dodgers: Eight years, $204 million
Buehler is currently in the second and final year of an extension with the Dodgers that pays him $4 million a year. His next deal will be a tad more pricey. Clayton Kershaw is still around in Dodger blue, but his injury history and mild decline resulted in 2021 being the year that Buehler became The Man in the rotation, reducing Kershaw to the role of deuteragonist. And while Los Angeles still has a rocking rotation, the depth isn’t quite what it was in recent years, so there should be more than slight concern that the franchise’s most valuable pitcher is unsigned. With Buehler two years from free agency, the Dodgers aren’t likely to get any massive discounts, but this is the best time to sign him if you don’t want to pay him Gerrit Cole money later. The Dodgers don’t necessarily have to stop at this figure, either; what’s the fun of being wealthy if you don’t use that cash to pay for cool things?
There may be some concern in some places about the dropoff in Buehler’s strikeout rate, but while strikeout rate changes do tend to stick very quickly, they stick far more when the underlying stats support the drop-off than when they don’t. In this case, the contact rates and swinging-strike rates haven’t worsened at all, nor has his velocity fallen off a cliff, suggesting that it’s a blip rather than a plunge. You can make a similar argument for the Dodgers signing Julio Urías to an extension, likely for a significantly lesser haul, but given the workload Buehler has shown he can handle, he’d be my priority. Read the rest of this entry »
Last week, I talked about a few young players who teams should be itching to sign to long-term contracts. Due to public demand, another set of projections is on the way, but I’ll admit I intentionally omitted one pitcher, Pablo López, from the first look because I wanted more space to talk about him.
Unlike a lot of pitchers the Marlins have accumulated during their various fire sales, López wasn’t a highly touted arm in the minors. Prior to 2017 — the season during which he and three other players were traded by the Mariners to the Marlins for reliever David Phelps — he was basically a non-entity among prospect-watchers. He didn’t receive an official ZiPS projection that year, but if he had, it would have been similar to the projection he received before the 2018 season, which essentially saw him as a below-average innings-eater at his peak. At no time did he rank on a ZiPS Top 100 prospect list.
His first couple of campaigns with the Marlins featured decidedly mixed results. While López was essentially a league-average pitcher thanks to exit velocities that ranked towards the top of the league (the good kind of top of the league), he lacked the ability to finish off batters. From 2018-19, he basically threw four pitches: a relatively straight fastball, a sinker, a curve, and a changeup. None them were whiff-makers, and none of them had even a 20% put-away rate, resulting in a mediocre 7.5 K/9 combined over those two seasons. Read the rest of this entry »
The Mets lost another starting pitcher on Thursday, as the team announced that the pain that forced Max Scherzer from his start Wednesday has been diagnosed as a moderate to high grade oblique sprain; the anticipated timetable for Scherzer’s return is six to eight weeks. After throwing a slider to Albert Pujols, Scherzer was in visible discomfort and quickly pulled the plug himself, sparing Buck Showalter the most dangerous part of a manager’s job: telling Max Scherzer to hit the showers:
The loss of Scherzer comes at a time the Mets are already down two other starting pitchers (three if you count Joey Lucchesi‘s loss to Tommy John surgery, which I’m not). Most notably, Jacob deGrom’s 2022 season has yet to begin due to a stress reaction in his right scapula. Tylor Megill is also currently on the IL due to biceps tendinitis diagnosed after the worst start of his professional career. Luckily, there’s reason to be hopeful in both cases. The most recent imaging of deGrom’s scapula indicated it is healing effectively, raising hopes that the ace’s return isn’t too far off. Meanwhile, Megill’s MRI didn’t reveal anything darker than a case of tendinitis, and he’s already scheduled to play catch today:
Jacob deGrom's MRI and CT scan revealed "considerable healing of the stress reaction on his scapula," Mets say.
He has been cleared to begin loading and strengthening his shoulder and will be "re-imaged in approximately three weeks."
Dan Szymborski: And we are here as this is a chat!
12:01
Guest: Martin Perez is on a tear! Small sample luck? Better pitch mix? Dead ball? Can any of this be sustainable?
12:02
Dan Szymborski: The dead ball helps him a bit. His cutter’s generally been working, and his peripheral numbers have improved too. He’s had runs where his cutter’s been working and he’s been effective, but he has had trouble keeping that up
12:02
M.F. Luder: Is there any hope for Alex Verdugo?
12:03
Dan Szymborski: Yeah, in fact, he has better advanced hitting stats better than most guys playing that poorly
12:04
Joey Baggadonuts: If/when the Nats call up Luis Garcia, what do you expect to see from him rest-of-season? He’s absolutely crushed AAA while being quite young for the level; Steamer seems like it’s underselling him…
The main reason why the Astros have been able to survive and thrive despite the departure of a large percentage of the core of their 2017 World Series-winning team is their success in developing their young talent. One of the most prominent of these players, Kyle Tucker, had his breakout season in the shortened 2020 and cemented those gains with a .294/.359/.557, 4.9 WAR 2021 campaign that saw him get his first MVP votes. With Tucker heading to arbitration this winter for the first time, the Astros discussed a long-term contract with their incumbent right fielder in recent weeks, but the deal has apparently fallen through.
The Astros recently spoke with Kyle Tucker’s camp about a contract extension, but the sides were unable to come to a deal and are no longer engaged, sources tell me and @brianmctaggart. Tucker will become arbitration-eligible for the first time at the end of this season.
While it hasn’t worked out, it’s the right idea. Teams want to lock up their best young players, and many players, especially before they get that first big arbitration bump, are interested in mitigating their personal risk. Wander Franco was more likely than not to beat the $182 million he’ll receive from the Rays and the team they trade him to around 2029, but it also provided him some real security, given he’s still a couple years from arbitration. These types of deals can be win-win.
So who should be the next players to get inked for the long haul? Here are my favorite picks. For each, I’ve included their ZiPS projections for both performance and a fair contract; after all, I don’t own a team, so I don’t have the motivation to pitch any absurdly team-friendly agreements like the one Ozzie Albies signed with the Braves. I’ve also omitted Juan Soto since we’ve already talked about him and a long-term deal quite a bit, most recently in Jay Jaffe’s piece before the season that already has the ZiPS projections. If you want a figure, let’s just say 10 years and all circulating US currency. Read the rest of this entry »
Pitchers getting injured is never good news, even in a year in which pitching talent seems relatively easy to come by. Sadly, we got a bunch of high-profile names hitting the IL over the weekend, so here’s a quick Monday rundown in case you were doing something more fun on Sunday than stressing about injuries, like watching the baseball games (non-Giants fans, at least).
Given the monumental task of replacing Jacob deGrom in the Mets’ rotation at the start of the season, Megill took his job surprisingly literally, doing his best imitation of the team’s ace. Through six starts, his ERA stood at 2.43 with a nearly identical FIP at 2.44, improving significantly on his major league debut in 2021. Then came the worst start of his professional career — including the minors — as he surrendered eight runs and didn’t even make it through the second inning against the Nationals last Wednesday. Megill can’t point to bad luck either; it’s hard to complain too strenuously about BABIP when you have an xBA of .563 and an xSLG of 1.263.
On the plus side, Megill’s velocity wasn’t down during that disaster of a start, and he didn’t report any discomfort until after the game. One thing that struck me, however, is how much his horizontal release point has changed in a lateral direction throughout the season. From his first start to his last outing, Megill’s horizontal release point has shifted about five inches; those release points tend to be far more consistent in-season, as players are more likely to tinker with this in the winter and spring. Release point inconsistency is a concern, and at least one study that I’m familiar with has linked shifting lateral release points with an eventual need for Tommy John surgery, albeit with low odds (a roughly 5% higher chance of a UCL tear with every 10 centimeters of movement). That’s getting ahead of ourselves, but it’s something to file in the back of your mind.
The decision to put Megill on the IL was made after he experienced soreness during his bullpen on Saturday, with biceps tendinitis as the announced culprit. Colin Holderman got the immediate call-up to take Megill’s spot on the roster, though that may be short-lived, as David Peterson started on Friday. Trevor Williams will get Megill’s start on Monday night against the Cardinals.
In other Mets injury news — of course there’s more, it’s the Mets — catcher James McCann will be out six weeks due to a broken hamate bone. Patrick Mazeika was called up and likely endeared himself to Mets fans more than McCann has by hitting the go-ahead home run in the seventh on Saturday against the Mariners. McCann’s offense has disappeared so quickly over the last year-plus that there’s not likely to be any real consequence for the Mets other than a thinning of the depth chart.
Amid a promising comeback campaign, Luzardo took a step back last week, walking four and allowing four runs in 2.2 innings against the Diamondbacks, bloating his ERA to 4.03. Like Megill, there were no suspicious velocity dropoffs — something to watch for given Luzardo’s injury history — but he reported forearm soreness after the game. In “crossing our fingers” news, he did not believe the pain was similar to what he experienced before his first Tommy John surgery, back when he was a high schooler in 2016:
I just started feeling a little something in the San Diego game, towards the back end of it, but nothing when I was pitching or anything like that. It was more just a little soreness. I kind of backed off a little between my starts. There wasn’t really pain or anything, more like stiffness.
The Marlins held off until this weekend to place Luzardo on the IL, retroactive to his May 10 start, when it became evident that he would be unavailable. It seems that Cody Poteet, already stretched out a bit in relief of Luzardo against Arizona and not used since, will get the spot start on Tuesday, with Sandy Alcantara going on Monday.
As for replacing Luzardo long-term, it doesn’t appear as if the Marlins plan to recall top prospect Max Meyer to fill the spot. My reading of the tea leaves is that they’re not going to push Edward Cabrera up soon as a replacement either; while he’ll get another chance in the not-too-distant future, I think Saturday’s start against Triple-A Nashville would have been a few tune-up innings rather than a 90-pitch outing if a callup was imminent.
Short of any additional bad news, it’s entirely possible that, with two off days in the next week, Luzardo may only miss just the one start.
Kershaw was a late scratch on Friday against the Phillies, pushing Walker Buehler’s start up a day on normal rest. Kershaw has a history of lower back pain and at least one instance (2012) of hip impingement, so the Dodgers are being careful with him. The culprit this time is inflammation of the SI joint, which, I believe, is the sacroiliac joint and not the Sports Illustrated joint; on the pelvis, it’s between the hip and the spine. As I did not attend Hollywood Upstairs Medical College, and my medical knowledge is primarily evaluating how sick I’ll feel if I eat some deliciously spicy food, let’s consult actual doctors here:
Biomechanically, the sacroiliac joint performs several functions. Primarily, its purpose is to attenuate the distribution of force loads from the lower extremities. It functions both as a shock absorber for the spine above and converts torque from the lower extremities into the rest of the body.
As pitching largely involves transfers of force between body parts, it’s understandable why the Dodgers see the need to be cautious. Last year was the first time Kershaw was placed on the IL with elbow issues, and given that it scared them enough to shut him down quickly for the postseason, this is not unexpected caution.
To replace Kershaw on the roster, the Dodgers called up Michael Grove, who got the start on Sunday and may get another down the road, though with a very quick hook. Andre Jackson looked like a rotation fallback option at the start of the season, but he’s failed to finish the third in each of his last three starts for Triple-A Oklahoma City, allowing 10 walks in just 3.1 innings.
If there’s anything as inevitable as the Tampa Bay Rays trading away a top starting pitcher, typically for salary reasons, it’s their development of the next one. Shane McClanahan looks a lot like their next one. The Baltimore native was highly effective in his rookie season, putting up a 3.34 ERA and 3.31 FIP with 10 strikeouts per nine over 25 starts in 2021. Even more impressive, he did it with minimal professional experience, with only four games in the high minors before becoming the first pitcher to make his major league debut in a playoff game.
2021 was a fine rookie season for McClanahan, but 2022 is looking like something special. In seven starts, his ERA stands at 2.52, and with a FIP of 2.67, it’s not a BABIP-fueled mirage. His strikeout percentage has jumped by about 40% year-on-year, from 27% to 38%, a notable improvement even in a very pitcher-friendly season. Batters are making both less contact than last year (dipping from 70.4% to 63.6%) and worse contact — their average exit velocity declined from 91.7 mph to 89.3, while their Statcast sweet spot percentage dipped from 36.8% to 26.5%. Among all pitchers with at least 20 innings thrown this season, only Corbin Burnes and Michael King have lower contact rates.
One of the primary differences between this season and last season for McClanahan has been the development of his changeup. Despite a fastball that can hit the high-90s with some nasty late break, McClanahan does not use his heat to finish off batters the way pitchers like Brandon Woodruff or Lance Lynn tend to. In fact, when batters get to him, it’s usually on the fastball, with a batting average well over .300 and 12 of his 19 career home runs allowed coming on the heater. Read the rest of this entry »
Jeff: What do we make of Semien? Same slow start as last year, or something else?
12:03
Dan Szymborski: I’m still on slow start.
12:03
Ryan: What language do you primarily code in? Does the answer depend on the project? I.e the ZIPS model vs. a random Thursday article research
12:04
Dan Szymborski: Depends. I’m not a coder, I’m a math guy who codes a little when he’s stuck doing. I use a combination of Excel with some statistical package third party add-ons and Visual Basic
Dan Szymborski
